Practitioner’s guide to valuation in the pharmaceutical, biotechnology, diagnostics, medical devices and wider life sciences and healthcare sector- get acquainted with state-of-the-art concepts and practices.
Introduction Getting the in-licensing discount rate wrong doesn’t just misprice a single pharmaceutical or biotech deal—it can quietly reshape a company’s entire portfolio risk profile over time. Every in-licensing decision…
How to Leverage EBITDA Multiples for Accurate Pharma Company Valuations Determining the valuation of pharmaceutical and biotechnology companies is a crucial exercise to inform high-impact decisions including organic investments and…
Understanding and Applying Discount Rates for Precise Biopharma Valuations Selecting the appropriate discount rate is essential for pharmaceutical and biotechnology valuations. The discount rate is one of the key drivers…
Mastering the Valuation of Pharma and Biotech Assets and Businesses Properly valuing drug and biotechnology assets is essential for pharmaceutical enterprises, biotech companies, investors, and other healthcare stakeholders. Valuation provides…
Introduction The pharmaceutical industry is at a critical inflection point in 2025, with research and development (R&D) continuing to grow despite global economic pressures and shifting regulatory landscapes. As thousands…
How to Navigate the Discount Rate Conundrum in Biotech and Pharma Valuation In the pharmaceutical and biotechnology industry (referred to collectively as biopharma), almost all valuation and investment decisions decisions…
Key Factors in Venture Capital Valuation of Healthcare and Life Sciences Startups Valuing early-stage healthcare and life sciences startups presents unique challenges due to their lack of revenue, high-risk profiles,…
Criteria and Strategies for Choosing the Right Comparable Companies in Biotech Valuation When valuing a private or public biotech company using market multiples, one of the most critical first steps…
How to Determine Accurate Addressable Market Size in Life Sciences Commercial Due Diligence Market size is one of the critical elements in the life sciences commercial due diligence, new product…